HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Schering Consent Decree Is Weighing Down Operations, CEO Says

This article was originally published in The Rose Sheet

Executive Summary

Schering-Plough's consumer division is among the hardest hit by the firm's ongoing FDA good manufacturing practices consent decree, according to the company

You may also be interested in...

Earnings In Brief

Schering-Plough: Sun care sales soared 60% to $78 mil. in the second quarter, "due to the timing of orders and shipments, coupled with favorable weather conditions," Coppertone marketer reports July 21. Consumer health care sales rose 19% to $317 mil., firm adds. Schering has "good work underway" on new Coppertone and Dr. Scholl's extensions, CEO Fred Hassan says during July 21 earnings call. However, consumer health gains were offset by struggles in Rx pharmaceuticals, spending connected to an FDA consent decree and restructuring costs, company states. Firm reports 7% net sales decline to $2.1 bil. and net loss of $65 mil...

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts